Related references
Note: Only part of the references are listed.Uncarboxylated osteocalcin ameliorates hepatic glucose and lipid metabolism in KKAy mice via activating insulin signaling pathway
Xiao-lin Zhang et al.
ACTA PHARMACOLOGICA SINICA (2020)
Newly identified peptide hormone inhibits intestinal fat absorption and improves NAFLD through its receptor GPRC6A
Bin Teng et al.
JOURNAL OF HEPATOLOGY (2020)
An osteocalcin-deficient mouse strain without endocrine abnormalities
Cassandra R. Diegel et al.
PLOS GENETICS (2020)
Osteocalcin is necessary for the alignment of apatite crystallites, but not glucose metabolism, testosterone synthesis, or muscle mass
Takeshi Moriishi et al.
PLOS GENETICS (2020)
The PNPLA3 rs738409 C>G variant interacts with changes in body weight over time to aggravate liver steatosis, but reduces the risk of incident type 2 diabetes
Ming-Feng Xia et al.
DIABETOLOGIA (2019)
Systematic review with meta-analysis: non-alcoholic fatty liver disease is associated with a history of osteoporotic fractures but not with low bone mineral density
Alessandro Mantovani et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Role of hyperglycaemia in the relationship between serum osteocalcin levels and relative skeletal muscle index
Yiting Xu et al.
CLINICAL NUTRITION (2019)
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair Younossi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
New insight into inter-organ crosstalk contributing to the pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Xu Zhang et al.
PROTEIN & CELL (2018)
Pharmacotherapy for NASH: Current and emerging
Monica A. Konerman et al.
JOURNAL OF HEPATOLOGY (2018)
Serum folic acid levels are associated with the presence and severity of liver steatosis in Chinese adults
Ming-Feng Xia et al.
CLINICAL NUTRITION (2018)
Multiple target tissue effects of GLP-1 analogues on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
Francesco Bifari et al.
PHARMACOLOGICAL RESEARCH (2018)
Association of adiposity indices with bone density and bone turnover in the Chinese population
J. Wang et al.
OSTEOPOROSIS INTERNATIONAL (2017)
Comparison of Ipragliflozin and Pioglitazone Effects on Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Randomized, 24-Week, Open-Label, Active-Controlled Trial
Daisuke Ito et al.
DIABETES CARE (2017)
Age- and sex-specific association of circulating osteocalcin with dynamic measures of glucose homeostasis
K. Y. Jung et al.
OSTEOPOROSIS INTERNATIONAL (2016)
Lower uncarboxylated osteocalcin and higher sclerostin levels are significantly associated with coronary artery disease
Kyoung Min Kim et al.
BONE (2016)
Association of nonalcoholic fatty liver disease with bone mineral density and serum osteocalcin levels in Korean men
Hae Jin Yang et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Osteocalcin improves nonalcoholic fatty liver disease in mice through activation of Nrf2 and inhibition of JNK
Jing Du et al.
ENDOCRINE (2016)
Inverse relationship between serum osteocalcin levels and nonalcoholic fatty liver disease in postmenopausal Chinese women with normal blood glucose levels
Yu-qi Luo et al.
ACTA PHARMACOLOGICA SINICA (2015)
Association between osteocalcin and metabolic syndrome in postmenopausal women
Suk Woo Lee et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2015)
Association between Serum Osteocalcin Levels and Non-Alcoholic Fatty Liver Disease in Women
Dong Hyun Sinn et al.
DIGESTION (2015)
Association of serum total osteocalcin with type 2 diabetes and intermediate metabolic phenotypes: systematic review and meta-analysis of observational evidence
Setor Kwadzo Kunutsor et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2015)
Assessment of liver fat content using quantitative ultrasonography to evaluate risks for metabolic diseases
Ming-Feng Xia et al.
OBESITY (2015)
Osteocalcin Protects Against Nonalcoholic Steatohepatitis in a Mouse Model of Metabolic Syndrome
Anisha A. Gupte et al.
ENDOCRINOLOGY (2014)
Testosterone Stimulates Duox1 Activity through GPRC6A in Skin Keratinocytes
Eunbi Ko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Relationship between serum osteocalcin levels and non-alcoholic fatty liver disease in Chinese men
Jianxin Dou et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2013)
Osteocalcin as a predictor of the metabolic syndrome in older persons: a population-based study
Mirjam M. Oosterwerff et al.
CLINICAL ENDOCRINOLOGY (2013)
The role of osteocalcin in human glucose metabolism: marker or mediator?
Sarah L. Booth et al.
NATURE REVIEWS ENDOCRINOLOGY (2013)
Interactions among bone, liver, and adipose tissue predisposing to diabesity and fatty liver
Giovanni Musso et al.
TRENDS IN MOLECULAR MEDICINE (2013)
Non-alcoholic fatty liver disease is associated with low bone mineral density in obese children
P. E. Pardee et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Review article: non-alcoholic fatty liver disease and osteoporosis - clinical and molecular crosstalk
Y. Yilmaz
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up
Shira Zelber-Sagi et al.
JOURNAL OF HEPATOLOGY (2012)
The skeleton as an endocrine organ
Douglas J. DiGirolamo et al.
NATURE REVIEWS RHEUMATOLOGY (2012)
Standardized Ultrasound Hepatic/Renal Ratio and Hepatic Attenuation Rate to Quantify Liver Fat Content: An Improvement Method
Ming-Feng Xia et al.
OBESITY (2012)
Insulin stimulation of SREBP-1c processing in transgenic rat hepatocytes requires p70 S6-kinase
Joshua L. Owen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
GPRC6A Mediates Responses to Osteocalcin in β-Cells In Vitro and Pancreas In Vivo
Min Pi et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Relation of osteocalcin with insulin resistance and histopathological changes of non alcoholic fatty liver disease
Rocio Aller et al.
ANNALS OF HEPATOLOGY (2011)
The Shanghai Changfeng Study: a community-based prospective cohort study of chronic diseases among middle-aged and elderly: objectives and design
Xin Gao et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
Direct demonstration that the vitamin k-dependent bone gla protein is incompletely γ-carboxylated in humans
James R. Cairns et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Thiazolidinediones and the liver in humans
Hannele Yki-Jarvinen
CURRENT OPINION IN LIPIDOLOGY (2009)
The measurement of broadband ultrasonic attenuation in cancellous bone - A review of the science and technology
Christian M. Langton et al.
IEEE TRANSACTIONS ON ULTRASONICS FERROELECTRICS AND FREQUENCY CONTROL (2008)
Endocrine regulation of energy metabolism by the skeleton
Na Kyung Lee et al.
CELL (2007)
Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: Executive summary
Geoffrey C. Farrell et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD
Paul Angulo et al.
HEPATOLOGY (2007)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Share Paper
